Reply to C.T. Matava et al

Sarah Alexander¹, John A Kairalla¹, Sumit Gupta¹+14

• ¹Sarah Alexander, MD, Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada; John A. Kairalla, PhD, Department of Biostatistics, University of Florida, Children's Oncology Group, Gainesville, FL; Sumit Gupta, MD, PhD, Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada; Emily Hibbitts, PhD, Department of Biostatistics, University of Florida, Children's Oncology Group, Gainesville, FL; Hannah Weisman, BSc, Children's National Hospital, Washington, DC; Doralina Anghelescu, MD, Division of Anesthesiology, St Jude Children's Research Hospital, Memphis, TN; Naomi J. Winick, MD, Department of Pediatric Hematology Oncology, University of Texas Southwestern Medical Center, Dallas, TX; Kevin R. Krull, PhD, Department of Psychology and Biobehavioral Sciences, St Jude Children's Research Hospital, Memphis, TN; Wanda L. Salzer, MD, Uniformed Services University, F. Edward Hebert School of Medicine, Bethesda, MD; Michael J. Burke, MD, Department of Pediatrics, The Medical College of Wisconsin Inc, Milwaukee, WI; Lia Gore, MD, Children's Hospital Colorado, University of Colorado, Aurora, CO; Meenakshi Devidas, PhD, Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN; Leanne Embry, PhD, University of Texas Health at San Antonio, San Antonio, TX; Elizabeth A. Raetz, MD, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Hospital, New York, NY; Stephen P. Hunger, MD, Division of Oncology and the Center for Childhood Cancer Research, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; Mignon L. Loh, MD, The Ben Towne Center for Childhood Cancer Research and the Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA; and Kristina K. Hardy, PhD, Children's National Hospital, Washington, DC.